Bauer H. Zweimueller-Mayer J. Steinbacher P. Lametschandtner A. Bauer H. C. (2010). The Dual Role of Zounla Occludens (ZO) Proteins. J. Biomed. Biotechnol. 2010, 402593. 10.1155/2010/402593
Beutheu Youmba S. Belmonte L. Galas L. Boukhettala N. Bôle-Feysot C. Déchelotte P. et al. (2012). Methotrexate Modulates Tight Junctions through NF-Κb, MEK, and JNK Pathways. J. Pediatr. Gastroenterol. Nutr. 54, 463–470. 10.1097/mpg.0b013e318247240d
Bhat A. A. Uppada S. Achkar I. W. Hashem S. Yadav S. K. Shanmugakonar M. et al. (2019). Tight junction Proteins and Signaling Pathways in Cancer and Inflammation: a Functional Crosstalk. Front. Physiol. 9, 1942. 10.3389/fphys.2018.01942
Bitoux M.-A. Stamenkovic I. (2008). Tumor-host Interactions: the Role of Inflammation. Histochem. Cel Biol 130, 1079–1090. 10.1007/s00418-008-0527-3
Brysse A. Mestdagt M. Polette M. Luczka E. Hunziker W. Noël A. et al. (2012). Regulation of CXCL8/IL-8 Expression by Zonula Occludens-1 in Human Breast Cancer Cells. Mol. Cancer Res. 10, 121–132. 10.1158/1541-7786.mcr-11-0180
Chae Y. K. Chang S. Ko T. Anker J. Agte S. Iams W. et al. (2018). Epithelial-mesenchymal Transition (EMT) Signature Is Inversely Associated with T-Cell Infiltration in Non-small Cell Lung Cancer (NSCLC). Sci. Rep. 8, 2918. 10.1038/s41598-018-21061-1
Dominguez C. David J. M. Palena C. (2017). Epithelial-mesenchymal Transition and Inflammation at the Site of the Primary Tumor. Semin. Cancer Biol. 47, 177–184. 10.1016/j.semcancer.2017.08.002
Dongre A. Weinberg R. A. (2019). New Insights into the Mechanisms of Epithelial-Mesenchymal Transition and Implications for Cancer. Nat. Rev. Mol. Cel Biol 20, 69–84. 10.1038/s41580-018-0080-4
Dutta P. Sarkissyan M. Paico K. Wu Y. Vadgama J. V. (2018). MCP-1 Is Overexpressed in Triple-Negative Breast Cancers and Drives Cancer Invasiveness and Metastasis. Breast Cancer Res. Treat. 170, 477–486. 10.1007/s10549-018-4760-8
González-Mariscal L. Lechuga S. Garay E. (2007). Role of Tight Junctions in Cell Proliferation and Cancer. Prog. Histochem. Cytochem. 42, 1–57. 10.1016/j.proghi.2007.01.001
González-Mariscal L. Miranda J. Gallego-Gutiérrez H. Cano-Cortina M. Amaya E. (2020). Relationship between Apical junction Proteins, Gene Expression and Cancer. Biochim. Biophys. Acta (Bba) - Biomembranes 1862, 183278. 10.1016/j.bbamem.2020.183278
Gottardi C. J. Arpin M. Fanning A. S. Louvard D. (1996). The junction-associated Protein, Zonula Occludens-1, Localizes to the Nucleus before the Maturation and during the Remodeling of Cell-Cell Contacts. Proc. Natl. Acad. Sci. 93, 10779–10784. 10.1073/pnas.93.20.10779
Kaihara T. Kusaka T. Nishi M. Kawamata H. Imura J. Kitajima K. et al. (2003). Dedifferentiation and Decreased Expression of Adhesion Molecules, E-Cadherin and ZO-1, in Colorectal Cancer Are Closely Related to Liver Metastasis. J. Exp. Clin. Cancer Res. 22, 117–123.
Kapur J. N. Sahoo P. K. Wong A. K. C. (1985). A New Method for gray-level Picture Thresholding Using the Entropy of the Histogram. Comp. Vis. Graphics, Image Process. 29, 273–285. 10.1016/0734-189x(85)90125-2
Kleeff J. Shi X. Bode H. P. Hoover K. Shrikhande S. Bryant P. J. et al. (2001). Büchler, M.W.,and Friess, HAltered Expression and Localization of the Tight junction Protein ZO-1 in Primary and Metastatic Pancreatic Cancer. Pancreas 23, 259–265. 10.1097/00006676-200110000-00006
Kyuno D. Takasawa A. Kikuchi S. Takemasa I. Osanai M. Kojima T. (2021). Role of Tight Junctions in the Epithelial-To-Mesenchymal Transition of Cancer Cells. Biochim. Biophys. Acta (Bba) - Biomembranes 1863, 183503. 10.1016/j.bbamem.2020.183503
Lesage J. Suarez-Carmona M. Neyrinck-Leglantier D. Grelet S. Blacher S. Hunziker W. et al. (2017). Zonula Occludens-1/nf-Κb/cxcl8: a New Regulatory axis for Tumor Angiogenesis. Faseb j 31, 1678–1688. 10.1096/fj.201600890R
Lévy L. Neuveut C. Renard C.-A. Charneau P. Branchereau S. Gauthier F. et al. (2002). Transcriptional Activation of Interleukin-8 by β-Catenin-Tcf4. J. Biol. Chem. 277, 42386–42393. 10.1074/jbc.m207418200
Lou Y. Diao L. Cuentas E. R. Denning W. L. Chen L. Fan Y. H. et al. (2016). Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma. Clin. Cancer Res.: official J. Am. Assoc. Cancer Res. 22. 10.1158/1078-0432.ccr-15-1434
Luczka E. Syne L. Nawrocki-Raby B. Kileztky C. Hunziker W. Birembaut P. et al. (2013). Regulation of Membrane-type 1 Matrix Metalloproteinase Expression by Zonula Occludens-2 in Human Lung Cancer Cells. Clin. Exp. Metastasis 30, 833–843. 10.1007/s10585-013-9583-8
Martin T. A. Watkins G. Mansel R. E. Jiang W. G. (2004). Loss of Tight junction Plaque Molecules in Breast Cancer Tissues Is Associated with a Poor Prognosis in Patients with Breast Cancer. Eur. J. Cancer 40, 2717–2725. 10.1016/j.ejca.2004.08.008
Mestdagt M. Polette M. Buttice G. Noël A. Ueda A. Foidart J.-M. et al. (2006). Transactivation of MCP-1/CCL2 by β-catenin/TCF-4 in Human Breast Cancer Cells. Int. J. Cancer 118, 35–42. 10.1002/ijc.21291
Oelkrug C. Ramage J. M. (2014). Enhancement of T Cell Recruitment and Infiltration into Tumours. Clin. Exp. Immunol. 178, 1–8. 10.1111/cei.12382
Otani T. Furuse M. (2020). Tight Junction Structure and Function Revisited. Trends Cel Biol. 30, 805–817. 10.1016/j.tcb.2020.08.004
Polette M. Mestdagt M. Bindels S. Nawrocki-Raby B. Hunziker W. Foidart J.-M. et al. (2007). β-Catenin and ZO-1: Shuttle Molecules Involved in Tumor Invasion-Associated Epithelial-Mesenchymal Transition Processes. Cells Tissues Organs 185, 61–65. 10.1159/000101304
Reichert M. Müller T. Hunziker W. (2000). The PDZ Domains of Zonula Occludens-1 Induce an Epithelial to Mesenchymal Transition of Madin-Darby Canine Kidney I Cells. J. Biol. Chem. 275, 9492–9500. 10.1074/jbc.275.13.9492
Resnick M. B. Gavilanez M. Newton E. Konkin T. Bhattacharya B. Britt D. E. et al. (2005). Claudin Expression in Gastric Adenocarcinomas: a Tissue Microarray Study with Prognostic Correlation. Hum. Pathol. 36, 886–892. 10.1016/j.humpath.2005.05.019
Romeo E. Caserta C. Rumio C. Marcucci F. (2019). The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System. Cells 8, 460. 10.3390/cells8050460
Smalley K. S. M. Brafford P. Haass N. K. Brandner J. M. Brown E. Herlyn M. (2005). Up-regulated Expression of Zonula Occludens Protein-1 in Human Melanoma Associates with N-Cadherin and Contributes to Invasion and Adhesion. Am. J. Pathol. 166, 1541–1554. 10.1016/s0002-9440(10)62370-x
Suarez-Carmona M. Bourcy M. Lesage J. Leroi N. Syne L. Blacher S. et al. (2015). Soluble Factors Regulated by Epithelial-Mesenchymal Transition Mediate Tumour Angiogenesis and Myeloid Cell Recruitment. J. Pathol. 236, 491–504. 10.1002/path.4546
Suarez-Carmona M. Lesage J. Cataldo D. Gilles C. (2017). EMT and Inflammation: Inseparable Actors of Cancer Progression. Mol. Oncol. 11, 805–823. 10.1002/1878-0261.12095
Thompson E. D. Zahurak M. Murphy A. Cornish T. Cuka N. Abdelfatah E. et al. (2017). Patterns of PD-L1 Expression and CD8 T Cell Infiltration in Gastric Adenocarcinomas and Associated Immune Stroma. Gut 66, 794–801. 10.1136/gutjnl-2015-310839
Van De Velde M. García-Caballero M. Durré T. Kridelka F. Noël A. (2018). Ear Sponge Assay: A Method to Investigate Angiogenesis and Lymphangiogenesis in Mice. Methods Mol. Biol. 1731, 223–233. 10.1007/978-1-4939-7595-2_20
Wang L. Chen Y. Li X. Zhang Y. Gulbins E. Zhang Y. (2016). Enhancement of Endothelial Permeability by Free Fatty Acid through Lysosomal Cathepsin B-Mediated Nlrp3 Inflammasome Activation. Oncotarget 7, 73229–73241. 10.18632/oncotarget.12302
Wen J. Zhao Z. Huang L. Wang L. Miao Y. Wu J. (2020). IL‐8 Promotes Cell Migration through Regulating EMT by Activating the Wnt/β‐catenin Pathway in Ovarian Cancer. J. Cel Mol Med 24, 1588–1598. 10.1111/jcmm.14848
Yang J. Antin P. Berx G. Blanpain C. Brabletz T. Bronner M. et al. (2020). Guidelines and Definitions for Research on Epithelial-Mesenchymal Transition. Nat. Rev. Mol. Cel Biol 21, 341–352. 10.1038/s41580-020-0237-9
